Companies/US/IEX

IDEX CORPORATION

Last · NYSE$238.62+1.43 (+0.60%)close · yahoo · 10h ago
Vol 636.8K ≈ 151.95M
Market cap$17.59B73.7M sh
P/E · TTM34.5fwd 24.8 · eps 6.91
Beta0.96vs S&P 500
Div yield1.23%annual · TTM
52w range
$160.60$243.80
Volume636.8Ksession

Issuer

Legal nameIDEX CORPORATION
HQUnited States (US)
ListingUS IEX
ISINUS45167R1041
SectorIndustrials
IndustryIndustrial Machinery & Equipment
SIC3561
CurrencyUSD
Entity registrysec:0000832101
CIK0000832101
Employees8,700
AddressIDEX Corp. 3100 Sanders Road 60062-7155, Northbrook +847 498 7070
Headline financial metrics
Revenue$1.8B
Operating income$372.3M
Net income$263.4M
Free cash flow$263.0M
Operating margin20.6%
Net margin14.6%
Return on equity6.6%
Period2026
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Strong HST backlog and higher EPS guidance outweigh still-guarded industrial trends.

Latest call · Q1 2026

Buy: IDEX delivered 5% organic sales growth, 10% organic orders growth, 26.0% adjusted EBITDA margin, and raised 2026 adjusted EPS guidance to $8.35-$8.55 from $8.15-$8.35.

HST is the clear engine—11% sales growth and 17% orders growth, supported by data center, semiconductor, space and defense demand—though the thesis still depends on acquired-business margin improvement while FMT and FSDP remain broadly flat and cyclical recovery is not yet broad-based.

Themes
  • H St Growth
  • Data Center Demand
  • Semiconductor
  • Space Defense
  • Water Platform
  • Industrial Recovery
+2

Near term

HST backlog growth and continued high-single-digit to double-digit demand should support execution through the next two quarters.

Q2 guidance calls for 3%-4% organic growth, 26.5%-27.0% adjusted EBITDA margin and $2.07-$2.12 adjusted EPS.

FMT orders rose 9% organically, led by water, mining and pumps, but revenue conversion remains a key near-term watchpoint.

Short-cycle industrial activity improved from January through April, but management characterized the recovery as mixed and modeled FMT and FSDP as flattish for the year.

The company plans to repurchase approximately $76 million of stock per quarter through 2026; tariffs are currently expected to have little net financial impact.

Longer term

HST has a credible multiyear runway in data-center power and thermal management, semiconductor consumables and equipment, optical switching, and space and defense.

IDEX's component orientation and early customer co-engineering may create switching costs and allow technologies to be redeployed across advantaged applications.

The 8020 operating model is being extended across integrated growth platforms, with capital and talent shifting toward higher-value markets and customers.

Bolt-on M&A remains active and can broaden the Materials Science Solutions and HST platforms while preserving the buyback program.

Water is a structural growth area through municipal storm-water infrastructure and high-purity water demand tied to semiconductor manufacturing.

Red flags

HST incremental EBITDA flow-through was only about 33% and is expected to reach merely the mid-30% range in 2026; management does not expect approximately 40% flow-through until potentially 2027.

Recently acquired businesses including Muon, Micro-LAM and Mott remain below HST's roughly 26%-27% segment EBITDA margin, making portfolio pruning and integration execution critical.

Life sciences remains pressured by China exposure, constrained NIH funding and academic spending; its recovery is an assumption behind longer-term HST margin expansion rather than an established trend.

Management explicitly said the guidance increase is driven more by internal growth initiatives and M&A than by a genuine cyclical industrial rebound.

FMT orders have outpaced sales for several quarters, and management retained a flattish full-year FMT outlook despite Q1 orders growth, limiting confidence in backlog conversion.

HST backlog visibility is better than IDEX's historical norm but is primarily within 12 months; longer-dated growth claims rely on customer discussions rather than firm disclosed commitments.

Forward outlook

revenue growth

3–4 pct

FY 2026

official guidance

ebitda

26.5–27 pct

FY 2026

official guidance

adjusted eps

8.35–8.55 $per share

FY 2026

official guidance

revenue growth

3–4 pct

Q2 2026

official guidance

ebitda

26.5–27 pct

Q2 2026

official guidance

adjusted eps

2.07–2.12 $per share

Q2 2026

official guidance

Recommendation history

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$2.24
Est. revenue
934.3M

Earnings transcripts

12 of 147 recent

Documents

FormReporting forFiledFlags
2026-09-162026-09-180
2026-09-162026-09-180
2026-09-112026-09-150
2026-08-292026-09-010